- CEO
- Koji Sawamura
- Full Time Employees
- 4,155
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Address
- Yebisu Garden Place Tower Tokyo TY Japan 150-6019
- IPO Date
- Mar 23, 2010
- Business
- NOF Corporation (NOFCF), founded in 1937 and headquartered in Yebisu Garden Place Tower, Shibuya-ku, Tokyo, operates as a diversified chemical manufacturer specializing in functional materials across life/healthcare, electronics/IT, and environment/energy sectors; its core products and services encompass oleo and specialty chemicals including fatty acids, surfactants, polyethylene glycol derivatives, and (meth)acrylate derivatives; functional chemicals and polymers such as organic peroxides, anti-fog agents, thermoplastic elastomers, polybutene, and electronics materials like capacitor additives and resist materials; explosives and propulsion systems comprising emulsion explosives, solid propellants, gun ammunitions, detonators, anti-freeze agents, and oceanographic survey devices; functional foods featuring margarine, shortenings, depanning oils, nutritional foods, and solubilized products; life science products including LIPIDURE biocompatible materials for contact lenses, eye/skin/oral care, hand sanitizers, and medical device coatings; DDS development offerings such as single molecular weight PEGs, nucleic acid delivery lipids, PEG lipids, and high-purity polysorbates; and anti-corrosion coatings like GEOMET waterborne chrome-free agents for automotive parts. The company maintains production bases in Japan including Amagasaki, Chidori, Daishi, Kinuura, Oita, and Taketoyo plants, with global operations through subsidiaries in the US (NOF America Corporation, NOF Metal Coatings North America), Europe (NOF Metal Coatings Europe), Asia (Changshu NOF Chemical in China, PT NOF MAS in Indonesia), and others serving automotive, pharmaceuticals, food, defense, and electronics industries. Recent developments include a strategic investment as minority shareholder and partner in Phosphorex in August 2024 to enhance lipid nanoparticle drug delivery capabilities via NOF's COATSOME SS-series; the launch of the NOF CORPORATION Open Innovation Program 2025 calling for proposals in thermal management, next-generation solar cells, displays, secondary batteries, and semiconductors; organizational consolidation in April 2023 forming the Functional Materials and Life Science divisions; acquisition of Hokkaido NOF Corporation by Nippon Koki in April 2024; and establishment of new Oita Works with LS Oita and LS Aichi plants in June 2024.